UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
FORM 10-K/A
[x] Amendment No. 3 to Annual Report Pursuant to Section 13 or 15(d) of the
Securities Exchange Act of 1934 (Fee Required) for the Fiscal Year Ended
December 31, 1996.
or
[ ] Transition Report Pursuant to Section 13 or 15(d) of the Securities
Exchange Act of 1934 for the transition period from __________ to
___________.
Commission File Number 0-16864
GULL LABORATORIES, INC.
-------------------------
(Exact Name of Registrant as Specified in its Charter)
UTAH 87-0404754
----------- -----------------
(State of Incorporation) (IRS Employer Identification Number)
1011 E. Murray Holladay Road
Salt Lake City, UT 84117
------------------------------ ----------
(Address of principal executive offices) (Zip Code)
Registrant's telephone number: (801) 263 - 3524
Securities registered under Section 12(b) of the Exchange Act:
Common Stock $.001 par value registered on the American Stock Exchange
Securities registered under Section 12(g) of the Exchange Act:
None
Indicate by check/mark whether the registrant: (1) has filed all
reports required to be filed by Section 13 or 15(d) of the Exchange Act during
the proceeding twelve months (or for such shorter period that the registrant
was required to file such reports), and (2) has been subject to such filing
requirements for the past ninety days. [x] Yes [ ] No
Indicate by check/mark if disclosure of delinquent filers pursuant to
Item 405 of Regulation 5K is not contained herein, and will not be contained,
to the best of registrant's knowledge, in definitive proxy or information
statements incorporated by reference in Part III of this Form 10-K or any
amendment to this Form 10-K. [ ]
The aggregate market value of the voting stock of the registrant held by
non-affiliates of the registrant as of March 17, 1997 was $21,784,940 based
upon the closing price on such date.
The number of shares of common stock outstanding as of March 17, 1997
was 6,588,696.
Documents Incorporated by reference: None
-1-
<PAGE>
Item 6: Selected Consolidated Financial Data of the
Registrant's Form 10-K for the Fiscal Year ended December 31, 1996 is hereby
amended to read in its entirety as follows:
ITEM 6: SELECTED CONSOLIDATED FINANCIAL DATA
The following table sets forth selected consolidated financial
information with respect to the Company for the periods indicated. This
information should be read in conjunction with the Company's consolidated
financial statements and related notes and "Management's Discussion and
Analysis of Financial Condition and Results of Operations" appearing herein.
- ------------------------------------------------------------------------------
Statement of Operations
(000's Omitted)
- ------------------------------------------------------------------------------
Year Ended December 31,
- ------------------------------------------------------------------------------
1996 1995 1994 1993 1992
----------------------------------------------
Sales $17,909 $18,828 $15,842 $15,406 $14,646
Net Income (loss) 241* 212* (311) (401) (507)
Net income (loss) per common
and common equivalent share 0.04 0.03 (0.05) (0.06) (0.08)
- ------------------------------------------------------------------------------
*See "1996 Compared to 1995" in "Results of Operations" below.
There were no cash dividends declared in the periods presented above.
- ------------------------------------------------------------------------------
Balance Sheet Data
(000's Omitted)
- ------------------------------------------------------------------------------
Year Ended December 31,
- ------------------------------------------------------------------------------
1996 1995 1994 1993 1992
-----------------------------------------------
Working capital $ 2,740 $ 125 $ 1,910 $ 2,064 $ 933
Total assets 12,353 12,318 11,502 10,446 11,336
Total long-term obligations 2,786 132 2,478 2,347 3,549
Stockholder's equity 4,975 4,741 4,080 4,493 3,177
- ------------------------------------------------------------------------------
-2-
<PAGE>
Signatures
Pursuant to the requirements of Section 13 or 15(d) of the
Securities and Exchange Act of 1934, the registrant has duly caused this
report to be signed on its behalf by the undersigned, thereunto duly
authorized.
GULL LABORATORIES, INC.
Date: July 15, 1997 By: /s/ George R. Evanega
----------------------------
George R. Evanega, Ph.D.
President and CEO
-3-
<PAGE>
Pursuant to the requirements of the Securities Exchange Act of 1934,
this report has been signed below by the following persons on behalf of the
registrant and in the capacities and on the dates indicated.
/s/ George R. Evanega Date: July 15, 1997
- -----------------------------------------
George R. Evanega President and Chief
Executive Officer
(Principal Executive
Officer)
Director
/s/ Michael B. Malan Date: July 15, 1997
- -----------------------------------------
Michael B. Malan Secretary/Treasurer
(Principal Financial &
Accounting Officer)
/s/ Myron W. Wentz Date: July 15, 1997
-----------------------------------------
Myron W. Wentz Chairman of the Board
of Directors
Date:
----------------------------------------- ------------------
Matthias Schmidt Director, Vice
Chairman
/s/ Gerd Krick Date: July 15, 1997
-----------------------------------------
Gerd Krick Director
/s/ Ulrich Wagner Date: July 15, 1997
-----------------------------------------
Ulrich Wagner Director
___________________________________________ Date:____________________
Anne-Marie Ricart Director
___________________________________________ Date:___________________
Peter Gladkin Director
-4-
